AGL 37.80 Decreased By ▼ -0.22 (-0.58%)
AIRLINK 206.98 Increased By ▲ 9.62 (4.87%)
BOP 9.53 Decreased By ▼ -0.01 (-0.1%)
CNERGY 5.98 Increased By ▲ 0.07 (1.18%)
DCL 8.95 Increased By ▲ 0.13 (1.47%)
DFML 36.45 Increased By ▲ 0.71 (1.99%)
DGKC 97.00 Increased By ▲ 0.14 (0.14%)
FCCL 35.60 Increased By ▲ 0.35 (0.99%)
FFBL 88.94 Increased By ▲ 6.64 (8.07%)
FFL 13.51 Increased By ▲ 0.34 (2.58%)
HUBC 127.70 Increased By ▲ 0.15 (0.12%)
HUMNL 13.68 Increased By ▲ 0.18 (1.33%)
KEL 5.40 Increased By ▲ 0.08 (1.5%)
KOSM 7.05 Increased By ▲ 0.05 (0.71%)
MLCF 44.93 Increased By ▲ 0.23 (0.51%)
NBP 60.16 Decreased By ▼ -1.26 (-2.05%)
OGDC 215.74 Increased By ▲ 1.07 (0.5%)
PAEL 40.42 Increased By ▲ 1.63 (4.2%)
PIBTL 8.31 Increased By ▲ 0.06 (0.73%)
PPL 194.15 Increased By ▲ 1.07 (0.55%)
PRL 39.12 Increased By ▲ 0.46 (1.19%)
PTC 26.45 Increased By ▲ 0.65 (2.52%)
SEARL 104.72 Increased By ▲ 1.12 (1.08%)
TELE 8.41 Increased By ▲ 0.11 (1.33%)
TOMCL 35.60 Increased By ▲ 0.60 (1.71%)
TPLP 13.49 Increased By ▲ 0.19 (1.43%)
TREET 22.31 Increased By ▲ 0.15 (0.68%)
TRG 61.15 Increased By ▲ 5.56 (10%)
UNITY 32.95 Decreased By ▼ -0.02 (-0.06%)
WTL 1.66 Increased By ▲ 0.06 (3.75%)
BR100 11,905 Increased By 178.9 (1.53%)
BR30 37,012 Increased By 635.6 (1.75%)
KSE100 110,952 Increased By 1438.8 (1.31%)
KSE30 34,948 Increased By 434.7 (1.26%)

A treatment for alcoholism can reactivate dormant HIV, potentially allowing other drugs to spot and kill the virus hiding out in human immune cells, researchers said. The medication, called Disulfiram, draws out the AIDS-causing virus without any side effects for patients, according to a study published in The Lancet.
In people undergoing treatment for AIDS, the virus can take cover in certain cells and hide away, only to reemerge once therapy is stopped.
This latency has been one of the biggest hurdles in developing a cure. "Waking up" the virus - and then destroying it - is a promising strategy for ridding patients of HIV.
But other drugs which are able to rouse HIV from its dormant state are toxic to humans.
In clinical trials led by Sharon Lewin, a professor at the University of Melbourne, 30 people on antiretroviral treatment (ART) were given increasing doses of Disulfiram over a period of three days.
At the highest dose, there was evidence of slumbering HIV being stimulated, with no side effects.
"This trial clearly demonstrates that Disulfiram is not toxic and is safe to use, and could quite possibly be the game changer we need," Lewin said in a statement.
The next step will be to test Disulfiram's rousing effect in combination with a virus-killing drug.
"Waking up the virus is only the first step to eliminating it," said the study's lead author Julian Elliott, head of clinical research in the department of infectious diseases at Alfred Hospital in Melbourne, Australia.
"Now we need to work out how to get rid of the infected cell." Approximately 34 million people have died of HIV-related causes world-wide. By the end of 2014, there were an estimated 36.9 people living with HIV globally.

Copyright Agence France-Presse, 2015

Comments

Comments are closed.